Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product


Product Description

Gecko 150 pixels JPEG1.jpgThe Gecko Microplate & Petri  Barcode Labeller is designed to deal with the day to day needs of either a high throughput or medium to low throughput lab. With a small footprint allowing limited bench space to be used, the Gecko is a versatile and robust instrument. With a Z-axis movement meaning that no adaptors are required and all label sizes able to be used the Gecko is a versatile, robust and reliable instrument. The Gecko uses either a 300dpi or 600dpi Zebra or Cab printer which is supplied as standard with the system and prints up to six fields (bar codes and human readable) per label. The label can be applied to one or all sides of the microplate and can withstand temperatures of -800C to 1000C. KBiosystems Gecko applies the label then verifies it using a mounted barcode reader before releasing the plate to give the end user full confidence. The data sources are numerous and can be comma-or tab delimited files and spread sheets, 3rd party application driven, pre-printed (sample feed and supply) and with an ODBC compliant LIMS.

The Gecko is easily integrated with stacking robots/stackers from KBiosystems as well as other systems and also be integrated within any OEM plate supply provider. The Gecko is the ideal printing and labelling solution in the market today with the added reassurance of dealing directly with the manufacturer.

Product Gecko
Company KBiosystems
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Units 5 to 10 Paycocke Close Basildon Essex

Tel: +44 (0) 1268 522431
Fax: +44 (0) 1268 270231

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos